Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
504.00    -8.00 (-1.56%)
Bid:
506.00
Ask:
507.00
Spread: 1.00 (0.198%)
Market Cap: £494.95m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Operational Update

16 Apr 2019 07:00

RNS Number : 2674W
Galliford Try PLC
16 April 2019
 

GALLIFORD TRY PLC

OPERATIONAL UPDATE

Galliford Try plc, the housebuilding, regeneration and construction group, announces that it is undertaking a strategic review of its Construction business.

The review will reduce the size of the Construction business, focusing on its key strengths in markets and sectors with sustainable prospects for profitability and growth, where we have a track record of success.

The review includes an assessment of operational progress and contract positions throughout the Construction business. The Board anticipates that this review will result in reduced profitability in the current year reflecting a reassessment of positions in legacy and some current contracts and the effect of some recent adverse settlements, as well as the costs of the restructure. The single largest element relates to the Queensferry Crossing joint venture, which has recently increased its estimated final costs on the project. With regard to the claim in respect of the completed Aberdeen Western Peripheral Route, and the previously disclosed £38m work in progress balance in respect of three contracts for a single client, our position is unchanged.

The Board expects that the outcome of this assessment will reduce the Group's full year post-exceptional profit before tax by £30m-£40m below the current consensus analysts' forecast1. The majority of our construction businesses continue to perform well, and these adjustments are not expected to have a significant impact on the Group's previous guidance on average net debt for the year.

The Board anticipates finalising its conclusions in the next few weeks and will share the detail of the review of the Construction business along with a further update on Group trading in its scheduled statement on 21 May 2019. 

This announcement contains inside information for the purposes of article 7 of EU Regulation 596/2014. The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel and Company Secretary.

 

For further enquiries:

Galliford Try

Graham Prothero, Chief Executive

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel & Company Secretary

 

01895 855001

Tulchan Communications

James Macey White, Martin Pengelley,

Elizabeth Snow

020 7353 4200

 

Notes to editors:

1. The mean of publicly available analysts' forecasts for profit before tax after taking into account exceptional items for the year ending 30 June 2019 is £156m based on company compiled consensus as at 15 April 2019.

2. Galliford Try plc is a leading UK housebuilding, regeneration and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2018, the Group generated revenue of £3.1bn.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDMMGMDRKMGLZM
Date   Source Headline
12th Sep 20187:00 amRNSFinal Results
4th Sep 201810:00 amRNSHolding(s) in Company
3rd Sep 20189:00 amRNSConfirmation of Directorate Change
21st Aug 201812:00 pmRNSHolding(s) in Company
1st Aug 20182:00 pmRNSTotal Voting Rights
24th Jul 20184:00 pmRNSHolding(s) in Company
19th Jul 201811:00 amRNSDirectorate Change
17th Jul 20187:00 amRNSTrading Statement
11th Jul 201812:00 pmRNSHolding(s) in Company
2nd Jul 201812:00 pmRNSTotal Voting Rights
27th Jun 20182:00 pmRNSBlock listing Interim Review
7th Jun 201810:00 amRNSDirector/PDMR Shareholding
5th Jun 20182:00 pmRNSDirector/PDMR Shareholding
1st Jun 201812:00 pmRNSTotal Voting Rights
25th May 201812:00 pmRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSTrading Statement
9th May 20184:00 pmRNSHolding(s) in Company
1st May 20184:00 pmRNSTotal Voting Rights
18th Apr 201812:00 pmRNSTotal Voting Rights
16th Apr 20183:15 pmRNSDirector/PDMR Shareholding
16th Apr 20182:43 pmRNSSuccessful Placing of Rights Issue Rump
16th Apr 20188:15 amRNSTotal Voting Rights
16th Apr 20187:25 amRNSResults of Rights Issue
9th Apr 20184:30 pmRNSDirector/PDMR Shareholding
6th Apr 20184:30 pmRNSHolding(s) in Company
6th Apr 201810:00 amRNSHolding(s) in Company
5th Apr 201810:30 amRNSDirector/PDMR Shareholding
3rd Apr 20184:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:00 pmRNSDirector/PDMR Shareholding
3rd Apr 201811:00 amRNSHolding(s) in Company
3rd Apr 201811:00 amRNSTotal Voting Rights
28th Mar 20182:30 pmRNSDirector/PDMR Shareholding
28th Mar 201811:00 amRNSDirector/PDMR Shareholding
27th Mar 20181:11 pmRNSPublication of Prospectus
27th Mar 20187:00 amRNSAnnouncement re: Rights Issue
20th Mar 201810:00 amRNSHolding(s) in Company
1st Mar 201812:00 pmRNSTotal Voting Rights
1st Mar 201810:00 amRNSHolding(s) in Company
14th Feb 20187:00 amRNSFully Underwritten £150 million Capital Raising
14th Feb 20187:00 amRNSHalf-year Report
5th Feb 201810:00 amRNSHolding(s) in Company
1st Feb 201812:00 pmRNSTotal Voting Rights
15th Jan 201811:04 amRNSJoint Venture with Carillion plc
2nd Jan 201812:00 pmRNSTotal Voting Rights
5th Dec 20173:00 pmRNSBlock Listing Application
4th Dec 201710:00 amRNSHolding(s) in Company
1st Dec 201712:00 pmRNSTotal Voting Rights
27th Nov 201712:00 pmRNSBlock listing Interim Review
17th Nov 201710:00 amRNSHolding(s) in Company
16th Nov 20177:00 amRNSContract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.